申请人:Kanda Yasuhiko
公开号:US20090062531A1
公开(公告)日:2009-03-05
A compound of the formula (I):
pharmaceutically acceptable salt or solvate thereof,
wherein
Y is a group of the formula:
wherein Ring A is optionally substituted aryl or optionally substituted heteroaryl, X
3
is COOR
17
or the like
Y is not optionally substituted phenyl which is substituted with the formula: —CR
9
R
10
X
3
at the para position,
R
1
to R
10
are each independently halogen, hydroxy, optionally substituted lower alkyl, optionally substituted aryl or the like,
X
1
is —O—, —S— or the like.